Lower Urinary Tract SymptomsNCT06505954
LOWER URINARY TRACT SYMPTOMS
An observational study of Lower Urinary Tract Symptoms, run by University of Gaziantep at 1 site in Turkey (Türkiye).
Trial summary
Lower urinary tract symptoms (LUTS) are observed in individuals with pathologies affecting the lower urinary system, such as detrusor overactivity, sphincter weakness, or sensory bladder disorder. LUTS can be categorized into storage, voiding, and post-micturition symptoms. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Lower Urinary Tract Symptoms
- What is being tested?
- Survey study
- How many people
- 278 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 12 Jun 2024to 30 Aug 2024
- How long will I take part?
- 3 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Medical students who have lower urinary tract symptoms are goal populations.
Who may be able to join
- -All medical students from committee 1 to 6.
Who cannot join
- Participants who filled out the survey questions incompletely or incorrectly
- Participants who had additional diseases
- Participants who used medication for psychiatric or cardiac reasons
- Participants who had undergone surgery that could affect bladder function
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Gaziantep University
Gaziantep, Şehitkamil, 27310
About this study
Official title: PREVALENCE OF LOWER URINARY TRACT SYMPTOMS AND CONTRIBUTING FACTORS AMONG MEDICAL STUDENTS
Lower urinary tract symptoms (LUTS) are observed in individuals with pathologies affecting the lower urinary system, such as detrusor overactivity, sphincter weakness, or sensory bladder disorder. LUTS can be categorized into storage, voiding, and post-micturition symptoms. Storage problems include increased frequency of urination, nocturia, urinary urgency, and incontinence. Voiding symptoms include decreased urine flow rate, hesitancy, and terminal dribbling, while post-micturition symptoms include post-micturition dribble and a sensation of incomplete bladder emptying. The prevalence of LUTS increases with age and is influenced by factors such as metabolic syndrome, gender, caffeine consumption habits, chronic psychological stress, bladder dysfunction, smoking, alcohol use, and constipation.
This study aims to investigate the prevalence of LUTS and contributing factors among medical students, a young population undergoing a stressful educational process.
A 43-question survey was prepared for all medical students from years 1 to 6. The survey included the Constipation Scoring System (CSS) to evaluate constipation, the Generalized Anxiety Disorder-7 (GAD-7) score to assess anxiety levels, and the Core Lower Urinary Tract Symptom Score (CLSS) to query LUTS. The survey also collected data on participants' dietary habits, smoking, alcohol and caffeine consumption, living conditions, age, gender, body mass index (BMI), and educational level. The study was approved by the local ethics committee of Gaziantep University (approval number 2024/234).
- Conditions
- Lower Urinary Tract Symptoms
- Being tested
- Survey study
- Keywords
- Lower Urinary Tract Symptoms, Medical students, Prevalence
- Medical subject headings
- Lower Urinary Tract Symptoms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Survey studyOther
Survey study among medical students about lower urinary tract symptoms
| Study group | Role | What they receive |
|---|---|---|
| 1 | Participant who has lower urinary tract symptoms Receives: Other: Survey study | |
| 2 | Participant who doesn't have lower urinary tract symptoms |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of lower urinary tract symptoms
Measured: Last six months
Secondary outcomes (1)
Contributing factors
data on participants' dietary habits, smoking, alcohol and caffeine consumption, living conditions, age, gender, body mass index (BMI), and educational level,anxiety level and constipation degree will be assessed.
Measured: Last six months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2024
- Study start12 Jun 2024
- Primary completion30 Aug 2024
- Study completion30 Aug 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lower Urinary Tract SymptomsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 278 participants (actual)
- Target duration
- 3 Months
Sponsor and investigators
- Lead sponsor
- University of Gaziantep
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muharrem Baturu, University of Gaziantep
- Investigators
- Muharrem Baturu, Study chair, Gaziantep University Faculty of Medicine, Department of Urology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06505954
- Sponsor's protocol ID
- GAUN-Urology-Baturu-002
- Status last verified
- Jul 2025
- First submitted
- 11 Jul 2024
- Last updated
- 25 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 25 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- PREVALENCE OF LOWER URINARY TRACT SYMPTOMS AND CONTRIBUTING FACTORS AMONG MEDICAL STUDENTS
- ClinicalTrials.gov ID
- NCT06505954
- Acronym / sponsor ID
- GAUN-Urology-Baturu-002
- Conditions
- Lower Urinary Tract Symptoms
- Keywords
- Lower Urinary Tract Symptoms, Medical students, Prevalence
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 278 participants (actual)
- Lead sponsor
- University of GaziantepUniversity, hospital or other
- Study start
- 12 Jun 2024 (actual)
- Primary completion
- 30 Aug 2024 (actual)
- Study completion
- 30 Aug 2024 (actual)
- First posted
- 17 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Lower urinary tract symptoms (LUTS) are observed in individuals with pathologies affecting the lower urinary system, such as detrusor overactivity, sphincter weakness, or sensory bladder disorder. LUTS can be categorized into storage, voiding, and post-micturition symptoms. Storage problems include increased frequency of urination, nocturia, urinary urgency, and incontinence. Voiding symptoms include decreased urine flow rate, hesitancy, and terminal dribbling, while post-micturition symptoms include post-micturition dribble and a sensation of incomplete bladder emptying. The prevalence of LUTS increases with age and is influenced by factors such as metabolic syndrome, gender, caffeine consumption habits, chronic psychological stress, bladder dysfunction, smoking, alcohol use, and constipation.
This study aims to investigate the prevalence of LUTS and contributing factors among medical students, a young population undergoing a stressful educational process.
A 43-question survey was prepared for all medical students from years 1 to 6. The survey included the Constipation Scoring System (CSS) to evaluate constipation, the Generalized Anxiety Disorder-7 (GAD-7) score to assess anxiety levels, and the Core Lower Urinary Tract Symptom Score (CLSS) to query LUTS. The survey also collected data on participants' dietary habits, smoking, alcohol and caffeine consumption, living conditions, age, gender, body mass index (BMI), and educational level. The study was approved by the local ethics committee of Gaziantep University (approval number 2024/234).
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 3 Months
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 1 | – | Other: Survey studyParticipant who has lower urinary tract symptoms |
| 2 | – | –Participant who doesn't have lower urinary tract symptoms |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Medical students who have lower urinary tract symptoms are goal populations.
Key inclusion criteria (1 listed)
- -All medical students from committee 1 to 6.
Key exclusion criteria (4 listed)
- Participants who filled out the survey questions incompletely or incorrectly
- Participants who had additional diseases
- Participants who used medication for psychiatric or cardiac reasons
- Participants who had undergone surgery that could affect bladder function
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Survey studySurvey study among medical students about lower urinary tract symptoms | Other | 1 |
Primary outcome
Prevalence of lower urinary tract symptoms
Time frame: Last six months
1 secondary outcome
Contributing factors
Time frame: Last six months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jul 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Lower Urinary Tract Symptoms
Not yet recruiting
Feasibility of Resisted Expiratory Muscle Training for Females Assigned at Birth With Stress Urinary Incontinence: A Pilot Study
Stress Urinary Incontinence
Not yet recruiting
Prostatic Artery Embolization Using Histoacryl as a Novel Embolizing Agent for Treatment of BPH
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
RecruitingPhase 2
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Urinary Urge Incontinence, Stress Urinary Incontinence
RecruitingPhase 4
Prophylactic Antibiotics for Outpatient Urethral Bulking
Urinary Tract Infections, Stress Urinary Incontinence
Recruiting
Ambulatory Long Length URodynamics Evaluation
Urology, Urinary Bladder, Overactive
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Muharrem Baturu study chair
Gaziantep University Faculty of Medicine, Department of Urology
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Lower Urinary Tract Symptoms, run by University of Gaziantep at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of lower urinary tract symptoms (time frame: Last six months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2025.